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Abstract
Multispecies probiotics have been reported to be more effective than monostrain
probiotics in health promoting for the host. In this study, 12 lactic acid bacteria
(LAB) strains were selected based on the level of induction of tumor necrosis factor
(TNF)-a in RAW 264.7 macrophage cells. Their adherence to Caco-2 cells and
inhibitory effects on Salmonella invasion of Caco-2 cells were compared. Strains
with different probiotic properties were then combined and BALB/c mice were fed
with LAB strains for 63 days; then the mice were challenged with Salmonella on day
64. For Salmonella-unchallenged mice that received a multistrain combination of
LAB strains that have greater TNF-a production in macrophages, greater adher-
ence and inhibit Salmonella invasion of Caco-2 cells to a greater extent, their
peritoneal macrophages had greater phagocytic activity. For Salmonella-challenged
mice, a significant reduction of Salmonella cells in the livers and spleens of the mice
was observed 8 days post challenge. The addition of 12% skim milk powder
together with LAB strain combinations significantly enhanced the reduction of
Salmonella cells in the mice livers and spleens. In conclusion, we have shown that
LAB strain combinations with particular probiotic properties when fed to mice can
inhibit Salmonella invasion of the liver and spleen.
Introduction
Lactic acid bacteria (LAB) strains may have beneficial effects
on human and animal health (Reid et al., 2006) and thus
have been widely used in yogurt processing, probiotic
products and feed supplements (Sakamoto et al., 2001;
Koebnick et al., 2003; Tsai et al., 2005). Recently, the normal
intestinal microbial community has been investigated as a
potential target for the management of immune disorders.
Various researchers have reported that LAB strains, such as
Lactobacillus spp., Bifidobacteria spp., Enterococcus spp.,
Lactococcus spp., Streptococcus spp., etc. may possess im-
mune-enhancing activities or are able to produce bacterio-
cins to protect the host from infection by pathogens (Gill
et al., 2001; Herich & Levkut, 2002; Cheikhyoussef et al.,
2008; Simova et al., 2009). The possible mechanisms by
which probiotics may offer protection against infection by
gastrointestinal pathogens have been addressed in diverse
patent applications and include the following: modification
of the intestinal environmental; competition with pathogens
for nutrients and colonization of adhesion sites in the
intestinal environment; competition with pathogens for
nutrients and sites on intestinal epithelium; production of
antimicrobial metabolites; and modulation of immune and
nonimmune defense mechanisms of the host (Timmerman
et al., 2004).
While the health effects of probiotics are genus, species
and strain specific, research suggests that multistrain and/or
multispecies probiotics are more effective than monostrain
probiotics (Zoppi et al., 2001; Shibolet et al., 2002; Timmer-
man et al., 2004). Multistrain or multispecies probiotics
contain different strains with characteristics, and therefore,
may be able to create an anaerobic probiotic niche that
enhances the colonization and survival of probiotic strains
at the expense of pathogens (Timmerman et al., 2004). In
addition, the probiotic properties of each strain, such as
FEMS Immunol Med Microbiol 63 (2011) 44–53c 2011 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
IM
M
U
N
O
LO
G
Y
 &
 M
ED
IC
A
L 
M
IC
RO
BI
O
LO
G
Y
colonization, biological activity and health-promoting
properties, may be enhanced by the additive and synergistic
effects that occur when these strains are used in combination
(Ouwehand et al., 2000; Shihata & Shah, 2000). On the other
hand, monostrain probiotics’ effects are limited to strain-
specific properties, and survival depends on the properties
of each specific strain. With the market potential growing,
increasingly more probiotic strains have been identified. For
LAB strains used in multistrain formulations, however, the
probiotic properties considered are, in general, merely their
antimicrobial activity, bile tolerance, growth in milk and
survival in the gastrointestinal tract (Casey et al., 2004). For
example, a five-strain combination formula has been devel-
oped to reduce pathogen infections in weaned pigs (Casey
et al., 2007). Another product, such as the commercially
available product VSL#3, an eight-strain LAB formulation,
was created by the addition of different strains to a formula-
tion in the hope that it will benefit the host (Bibiloni et al.,
2005). There are very few reports regarding multistrain
probiotic products composed of LAB strains with selected
functions, such as immunomodulation activity, adherence
to host intestinal epithelium and inhibition of host invasion
by pathogenic bacteria.
Previously, we have shown that the combination of
different heat-killed strains of the same LAB species, i.e.
Lactobacillus acidophilus, was able to retard the invasion of
Salmonella Typhimurium in mice. This antagonistic effect
may have been due to the immune-enhancing effects of the
heat-killed LAB strains (Lin et al., 2007). In this study, we
attempted to develop a LAB combination consisting of
different species and to evaluate their effectiveness in redu-
cing infections by Salmonella in mice. Such a preparation
may be useful as a human probiotic or as an animal feed
supplement. For this purpose, 146 different LAB strains,
including Lactobacillus spp., Enterococcus spp., Bifidobacter-
ium spp. and Pediococcus spp., were evaluated for their
immunomodulating activity. Strains that increased tumor
necrosis factor (TNF)-a production by macrophages the
most were then evaluated for their probiotic properties
including resistance to gastrointestinal conditions, adher-
ence to Caco-2 cells, their antimicrobial activities against the
growth of common pathogenic bacteria and their inhibitory
effects on Salmonella invasion of Caco-2 cells. Strains were
then selected and combined into several multispecies for-
mulations and these formulations were compared for their
effectiveness in protecting mice from Salmonella infection.
Materials and methods
Bacteria strains and their growth conditions
A total of 146 LAB strains including Lactobacillus spp.,
Enterococcus spp., Bifidobacterium spp. and Pediococcus spp.
were evaluated for their immunomodulating activity. The 12
strains that stimulated the highest TNF-a production
in macrophages are shown in Table 1 and Fig. 1. The stock
cultures of the 146 strains were maintained at  70 1C in
20% glycerol. Before experimental use, bacteria were propa-
gated twice in Lactobacilli deMan Rogosa Sharpe (MRS)
broth (Difco, Maryland) containing 0.05% L-cysteine for
24 h at 37 1C.
Other bacterial strains used in this study included Sta-
phylococcus aureus, enterotoxigenic Escherichia coli, entero-
haemorrhagic E. coli, Salmonella enterica serovar Enteritidis
and serovar Typhimurium and are listed in Table 1. For the
cultivation of these bacteria strains, one loopful of each
strain was inoculated into 5mL a tryptic soy broth and
incubated at 37 1C for 12 h. Then, a portion of the culture
was diluted and placed on a tryptic soy agar for future
studies.
Culture of cell lines
Human epithelial-like cell line Caco-2 and mouse BALB/c
macrophage RAW 264.7 cells were obtained from the
Bioresource Collection and Research Center (BCRC),
Hsin-Chu, Taiwan. Caco-2 cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) (Gibco) supplemented
with 10% (v/v) fetal bovine serum and 1% 100X Penicillin-
Streptomycin (HyClone, Logan, UT). RAW 264.7 cells were
cultured in a monolayer with RPMI-1640 medium (Hy-
Clone) supplemented with 10% (v/v) fetal bovine serum,
1% 100 Penicillin–Streptomycin (HyClone) and 1%
100 MEM-nonessential amino acid solution (HyClone).
For cell culture assay, cells were cultured in 75-cm2 plastic
tissue culture flasks (Nunc, Roskilde, Denmark). RAW 264.7
cells were used at the late confluence stage after 5 days of
incubation at 37 1C and Caco-2 cells were used at the
differentiated stage after 21 days of incubation at 37 1C. For
both incubations, a 5% CO2/95% air atmosphere was used.
Table 1. Bacterial strains used in this study
Strains and strain number
Lactobacillus spp.: Lactobacillus acidophilus LAP5; L. brevis LBR01
(BCRC12945); L. fermentum LF01; L. fermentum LF33; L. fermentum
LF50; L. plantarum LPL05 (BCRC10069); L. rhamnosus LRH02; L. reuteri
LRE01 (BCRC 14625)
Pediococcus spp.: Pediococcus acidilactici PA05; P. inopinatus PI08
Enterococcus spp.: Enterococcus faecium TM39; E. casseliflavus ECA01
(BCRC 14926)
Pathogenic bacteria: Staphylococcal aureus enterotoxin A (SEA, BCRC
13824); S. aureus enterotoxin B (SEB, BCRC 13825); S. aureus
enterotoxin C (SEC, BCRC 13828); S. aureus enterotoxin D (SED, BCRC
13829); Enterotoxigenic Escherichia coli (LTIp, ATCC 37218);
Enterohaemorrhagic E. coli O157:H7 (STI+SLTII, ATCC 43894);
Salmonella Enteritidis ATCC 13076; S. Typhimurium ATCC 14082
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Adhesion of LAB to the Caco-2 cells
The conditions described by Tsai et al. (2004b) for the
adhesion study of LAB cells were followed. Caco-2 cells were
transferred (5 104 cellsmL1) to 24-well multidishes con-
taining a fresh tissue culture medium without Penicillin–
Streptomycin. The mixture was kept at 37 1C in a 5% CO2/
95% air atmosphere until cell lines grew to a monolayer in
each well. Bacterial cells of each strain, after washing with
phosphate-buffered saline (PBS), were resuspended in 1mL
DMEM, and 100mL of each suspension was transferred to
the 24-well multidish (1 108 CFUmL1) containing the
Caco-2 cells and then incubated for 2 h. After incubation,
cells were washed twice with PBS, fixed with 10% formalin
for 30min, washed four times with PBS and then stained
with crystal violet for 5min. The number of adherent LAB
cells was counted according to the method of Gopal et al.
(2001). Ten of the Caco-2 cells were used to calculate the
average number of the adherent LAB cells per Caco-2 cell.
Assays for TNF-a production by macrophage
RAW264.7 after stimulation with LAB strains
RAW 264.7 cells were cultured in triplicate, at a density of
1 106 cellsmL1 of RPMI-1640 medium without Penicil-
lin–Streptomycin, in 24-well tissue culture plates. LAB cells
were centrifuged at 7000 g for 10min and the pellet was
resuspended in RPMI-1640 medium containing RAW 264.7
cells to a final concentration from 108 to 109 CFUmL1.
Lipopolysaccharide from E. coli O26:B6 (Sigma) was used as
a positive control. After 24 h, 48 h and 72 h, the cytokines
produced in these culture supernatants were analyzed.
Cytokines were measured using an ELISA kit purchased
from Bender MedSystems Inc. (San Diego, CA) for mouse
TNF-a. Ninety-six-well Immuno-Maxisorp plates (Nunc)
were coated with monoclonal antibodies for TNF-a, and
then diluted and placed in coating buffer (1PBS) over-
night at 4 1C. Plates were blocked and washed. Culture
medium was added to the plates and they were incubated
for 2 h at room temperature. Plates were then washed again,
and biotinylated anti-mouse TNF-a and horseradish perox-
idase-conjugated streptavidin were added for the detection
of TNF-a, followed by incubation for 1 h at room tempera-
ture. The chromogenic reactions were developed with the
3,30,5,50-tetramethylbenzidine substrate for 30min at room
temperature and were terminated with 2N H2SO4 and the
A450 nm was measured. Equivalent levels of TNF-a were
calculated by comparison with a reference curve generated
using TNF-a standards. The results were expressed as the
concentration of the cytokine in serum (pgmL1).
Acid and bile resistance of the LAB
To evaluated acid and bile resistance among the LAB strains, the
methods described by Tsai et al. (2005) were used. In general,
100mL of each culture containing about 108–109CFUmL1 of
LABwas suspended in PBS. The pHwas adjusted to 2.0, 2.5 and
3.2 using 0.1N HCl and the mixture was incubated at 37 1C for
3h. Control incubations of each LAB strain were performed at
pH 7.2 under the same conditions. After incubation, viable
bacterial counts were determined by plating serial dilutions of
the culture in PBS (pH 7.2) on MRS agar (Merck, Darmstadt,
Germany). LAB that survived the acid tolerance study were
centrifuged (5000 g, 5min), washed with PBS (pH 7.2) and
then grown in 9mL MRS broth with and without 0.3% (w/v)
oxgall bile (Sigma). Viable bacterial counts were determined by
plating serial dilutions on MRS agar.
Antimicrobial activity assay
The antibacterial activity of LAB strains was studied using
the agar diffusion test. Strains of LAB were grown over-
night (20 h) in an MRS broth at 37 1C. The cultures were
centrifuged and the supernatants were recovered. Pathogenic
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Fig. 1. TNF-a production by RAW264.7
macrophage cells after incubation with different
LAB strains.
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bacterial strains were grown on Luria–Bertani agar (LA).
Then, wells were hollowed out of the LA plates and 100mL of
the spent culture supernatant (LAB-SCS) was dropped into
each well and the culture was incubated at 37 1C for 14 h. The
antimicrobial activity was determined by measuring the clear
zone around the wells. LAB strains with inhibition zones
o 11, 11–16, 17–22 and 4 23mmwere classified as strains of
no  ; mild1; strong11; and very strong111 inhibition,
respectively (Rammelsberg & Radler, 1990).
Inhibition of Salmonella invasion of Caco-2 cells
by LAB strains
The Caco-2 cells were transferred (1 105 cellsmL1) with
0.05% trypsin to 96-well tissue culture plates containing a
fresh tissue culture medium and cultured for 20–22 h. The
wells were then washed three times with PBS and about
N (N= 1–9) 107 CFU per well of each LAB strain was
added and incubated for 1 h at 37 1C in a 5% CO2 incubator.
About 5 107 CFU per well of Salmonella cells were added
to wells containing the Caco-2 cell culture monolayers and the
cells were incubated for 2 h at 37 1C in a 5% CO2 atmosphere.
The wells were then washed three times with PBS and
incubated for another 1 h in a fresh DMEMmedium contain-
ing 100mg gentamicinmL1. After incubation, each well was
again washed with PBS three times and then Caco-2 cells were
lysed with 100mL of 1% Triton X-100. Appropriate dilutions
were spread onto a plate count agar and the plates were
incubated at 37 1C overnight. The bacterial counts were
calculated to measure Salmonella invasion.
Mice
The animal experiments were approved by the Institutional
Animal Care and Use Committee of Hung Kuang University,
Taichung County, Taiwan (approval No. 96022). Mice free
from specific pathogens were used in this study. All were
male inbred strains of BALB/c mice weighing 20–22 g that
were 8 weeks old when purchased from the National
Laboratory for Animal Breeding and Research Center,
Taipei, Taiwan. These mice were raised at 20 2 1C,
55 5% of RH%, under a 12-h light cycle. They were fed
laboratory rodent diet 5001 (manufactured by PMI Nutri-
tion International Inc. Richmond, IN) sterilized by g
irradiation. Mice were fed ad libitum for 1 week before being
used in the study. On treatment day 0, the mice were
randomly allocated into six groups of 10 mice. The feed
intake and body weight of each mouse was measured weekly.
Multistrain combinations of LAB strains
LAB strains in the multistrain groups were individually
grown and then mixed. All probiotic preparations were
cultured to check their viability and for enumeration.
Strains used in multistrain probiotic preparations were
either randomly selected or were selected based on their
probiotic properties, including enhancing TNF-a produc-
tion in macrophages, inhibition of the growth of pathogenic
bacteria and adherence to Caco-2 cell lines. Strains in
multistrain Formula I (F I) were LAP5, TM39, LF33 and
LPL05. Strains in F II were ECA01, PI08, LF01 and PA05 and
strains in F III were LF50, LBR01, PA05 and LF01 (Table 2).
For F I and II, in addition to the LAB cells, the effects of 12%
skim milk powder (SMP) were also investigated.
LAB feeding, Salmonella challenges and assays
of the phagocytic activity of peritoneal
macrophages from mice
Themethods of LAB feeding and pathogen challenge described
by Hudault et al. (1997) were used. LAB strains were grown in
an MRS broth (Difco) at 37 1C for 20 h. After centrifugation
(5000 g) at 4 1C, bacterial cells were resuspended in ddH2O
and adjusted to a cell density of 1 1010CFUmL1. Each
mouse was fed a single 0.2-mL dose of a known concentration
of LAB strains (1 1010CFUmL1) daily for 28 consecutive
days and a 0.1-mL dose of LAB strains (1 1010CFUmL1)
daily from the 29th to the 63rd day. Mice were offered a basal
diet (MF-18, Oriental Yeast Co. Ltd) and water ad libitum. The
Table 2. Effect of LAB culture on the invasion of Caco-2 cells by
Salmonella Typhimurium
Lactic acid bacteria strains
Salmonella invasion
(log CFU mL1)z
Control DMEM medium 4.50 0.15
L. fermentum LF01 2.48 0.00
E. casseliflavus ECA01 2.30 0.00
L. fermentum LF33 2.18 0.15
E. faecium TM39 1.65 0.15
L. brevis LBR01 1.00 0.00
L. fermentum LF50 2.00 0.00
P. acidilactici PA05 4.57 0.55
L. plantarum LPL05 o 1
L. acidophilus LAP5 o 1
P. inopinatus PI08 o 1
Formula I (Lactobacillus acidophilus
LAP51Enterococcus faecium TM391L.
fermentum LF331L. plantarum LPL05)
1.18 0.15
Formula II (E. casseliflavus ECA011P. inopinatus
PI081L. fermentum LF011P. acidilactici PA05)
2.30 0.15
Formula III (L. fermentum LF501L. brevis
LBR011P. acidilactici PA051L. fermentum LF01)
3.91 0.33
Value indicates a significant difference (Po 0.05) from the PBS-nega-
tive control.
wExperimental conditions are described in Materials and methods. The
inoculum level of Salmonella Typhimurium ISM50 was 7.6 0.2 log
CFU mL1.
zIntracellular Salmonella numbers in the suspension of the lysed cells (see
Materials and methods).
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six groups of mice (10 mice each group) were fed with F I, F II,
F III and ddH2O, respectively. For F I- and F II-fed mice, the
effects of 12% SMP in the multistrain preparation were also
investigated. During the 63-day feeding period, the growth rate
of eachmouse was measured weekly. After 63 days, five mice in
each group were challenged with S. Typhimurium ISM 50 by
an oral administration of a single 0.2-mL dose of Salmonella
cells (5 107CFUmL1). Strain ISM50 was isolated from a
patient with salmonellosis by the National Institute of Pre-
ventive Medicine, Department of Health, Taipei, Taiwan.
Before Salmonella challenge, another five mice in each group
were killed and the phagocytic activity of peritoneal macro-
phage cells of the BALB/c mice was assayed. For the Salmo-
nella-challenged mice, on day 8 after challenge, the numbers of
Salmonella in the livers and spleens of the mice were deter-
mined using the method of Tsai et al. (2005). Five mice of each
of the challenge groups were killed by cervical dislocation. The
spleens and livers were removed aseptically. These organs were
mixed in sterile water to a final volume of 5mL and were
homogenized. Cell suspensions were serially diluted with PBS
and 1mL of the dilution was plated on brilliant green agar.
After 48h of incubation at 37 1C, Salmonella colonies (CFU)
were enumerated.
To assay the phagocytic activity of peritoneal macrophage
cells in BALB/c mice fed with different multistrain formulas,
the methods described and modified by Chow et al. (2010)
were used. Macrophage cells (1 106) from the mice were
seeded in a 96-well plate and incubated overnight at 37 1C. The
cells were washed three times with PBS and then exposed to
BioParticalss FITC-conjugated E. coli at a multiplicity of
infection of 10 : 1. The plates were centrifuged at 4 1C, 250 g,
for 5min to facilitate contact between bacteria and peritoneal
macrophage cells before incubating at 37 1C. After 2h of
incubation, cells were washed three times with PBS and then
mixed with 50mL 2 trypan blue solution in 50mL analysis
buffer (10% fetal bovine serum and 1% 100 MEM-non-
essential amino acid solution in RPMI-1640 medium) before
being analyzed by flow cytometry using a FACStarPLUS.
Statistical analysis
Data were expressed as mean SD and the statistical
significance was determined using a one-way ANOVA, fol-
lowed by Duncan’s new multiple range test using the
Statistical Analysis System SAS Enterprise Guide 2.1.40.
Statistical significance was considered as Po 0.05.
Results
Selection of LAB strains by assay with TNF-a
In order to screen the LAB strains with immunomodulating
activity, the enhancement of TNF-a production by RAW
264.7 macrophage cells following coincubated with each
LAB strain was measured. A total of 146 LAB strains were
screened, and the TNF-a production levels for the top 12
LAB strains were all higher than 30 ngmL1 (Fig. 1). The
sources of these 12 LAB strains are given in Table 1. The
TNF-a level of 80 ngmL1 for RAW 264.7 cells was obtained
with lipopolysaccharide (10mgmL1) (Sigma), which served
as the positive control while the undetectable level of TNF-a
for macrophage cells in DMEM medium only was used as
the negative control (Fig. 1). LAB strains LF33, LAP5 and
TM39 enhanced TNF-a production more than lipopolysac-
charide did in the macrophage cells. The TNF-a levels for
the other 9 LAB strains (strain PA05 to LPL05) were between
30 and 50 ngmL1 (Fig. 1). The TNF-a levels for these
12 LAB strains are shown in Fig. 1. All of the remaining
134 LAB strains enhanced TNF-a production to levels
o 20 ngmL1 (data not shown). These strains were not
studied further.
Adherence and acid and bile tolerance among
LAB strains
The 12 LAB strains that enhanced TNF-a production the
most were examined for their ability to adhere to the human
colon cell line Caco-2 (Table 3). Five strains (PI08, LAP5,
TM39, LF33 and LPL05) showed strong adherence to Caco-
2 cells (4 200CFU LAB per Caco-2 cell). Strain PA05
showed moderate adherence (about 110CFU LAB per
Caco-2 cell). The rest of the strains showed lower adherence
(from 18 to 78CFU per Caco-2 cell). Based on the methods
described for the assay of the acid and bile resistance of the
LAB, all of the 12 selected LAB strains were acid tolerant to
pHZ2.5 and less tolerant at pH 2.0. For bile tolerance,
strains of animal origins, such as LAP5, TM39 and LF33,
were tolerant to bile while strains of vegetable origin were
generally less tolerant (Tanaka et al., 1999; Tsai et al., 2004b).
Table 3. Adhesion of LAB to Caco-2 cells
Strain
Average number of adherent
bacteria per Caco-2 cell
Pediococcus inopinatus PI08 2712.22
Lactobacillus acidophilus LAP5 2631.43
Enterococcus faecium TM39 2471.63
L. fermentum LF33 2072.63
L. plantarum LPL05 2062.57
P. acidilactici PA05 1102.36
L. brevis LBR01 782.82
L. reuteri LRE01 591.60
L. rhamnosus LRH02 451.84
L. fermentum LF50 361.43
L. fermentum LF01 190.88
E. casseliflavus ECA01 180.92
Method for the calculation of the average number of the adherent LAB
cells per Caco-2 cell is shown in Materials and methods.
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Effects of SCS of LAB strains on the growth of
pathogenic bacteria
When E. coli, Salmonella Typhimurium, enterotoxigenic S.
aureus and Bacillus cereus (Table 1) were used as indicator
bacteria, most of the above-mentioned 12 LAB strains were
able to inhibit the growth of these pathogenic bacteria
although some, such as LF50, TM39, LBR01, LF01 and
ECA01, showed low or no antimicrobial activity against
certain bacteria strains, such as enterotoxigenic S. aureus.
The levels of antimicrobial activity for these 12 LAB strains
are shown in Table 4.
Inhibitory effects of LAB strains and multistrain
formulations on the Salmonella invasion of
Caco-2 cells
LAB cultures were used to study the inhibitory effects of
LAB on the Salmonella invasion of Caco-2 cells. Table 2
shows that the invasion rate of Caco-2 cells by S. Typhimur-
ium decreased significantly when salmonellae were coincu-
bated (2 h) with the cultures of certain LAB strains. Strains
LPL05, LBR01, LAP5 and PI08, LBR01 and TM39 signifi-
cantly inhibited the Salmonella invasion of Caco-2 cells as
compared with the control without LAB.
Based on the above characteristics for individual LAB
strains, multistrain formula I (F I) was prepared using
strains with strong adherence (4 200CFU per Caco-2 cell),
high TNF-a-enhancing activity (Fig. 1), high antimicrobial
activity and the most inhibitory effects on Salmonella
invasion. Meanwhile, two other multistrain formulas, each
containing strains with different levels of probiotic proper-
ties, were used for comparison. Formula II (F II) consists of
strains with medium TNF-a-enhancing activity and strains
with high or low adherence. Formula III (F III) consists of
strains with low or medium adherence as well as TNF-a-
enhancing activity. As stated above, F I also inhibited S.
Typhimurium invasion of Caco-2 cells to the greatest extent
(Table 2).
Uptake of labeled E. coli by BALB/c mice
macrophage cells
The effects of LAB on the phagocytosis of macrophage cells
from BALB/c mice were determined. Each day, the mice
were orally administered with water (control), or F I, II
(with or without 12% SMP) or III [N (N= 1–9) 109 CFU
each LAB per mouse] for a period of 64 consecutive days.
Statistical analysis indicated a significant increase (Po 0.05)
in the phagocytotic activity (%) of macrophage cells from
mice fed with F I, followed by F II when flow cytometry with
FACStarPLUS was used for the measurement of phagocyto-
sis (Fig. 2). In order to evaluate the effect of 12% SMPon the
phagocytosis, the effect on the phagocytosis with F II plus
SMP was assayed. Phagocytosis was not affected by the
addition of SMP (data not shown).
Inhibitory effects of multistrain formulas with
or without SMP on the invasion of Salmonella to
mouse liver and spleen
After feeding with multistrain formulas for 63 days, mice were
orally challenged with S. Typhimurium (ISM 50, 1 107CFU
per mouse) and after another 8 days, they were killed and
analyzed for the counts of viable Salmonella cells in their
spleens and livers. Viable Salmonella counts in the spleens and
livers of the mice fed with F I significantly decreased
(Po 0.05) compared with the counts obtained from the
Table 4. Antimicrobial activity of SCS of LAB against pathogenic bacteria
LAB strains
Staphylococcal enterotoxin (SE) S. aureus
Enterotoxigenic
E. coli (ETEC)
Enterohaemorrhagic
E. coli (EHEC) S. Enteritidis S. Typhimurium
SEA BCRC
13824
SEB BCRC
13825
SEC BCRC
13828
SED BCRC
13829
ATCC
35401
ATCC
43894
ATCC
13076
ATCC
14028
L. fermentum LF50     1 1 1  
P. acidilactici PA05 1 1  11 1 1 1 1
L. plantarum LPL05 1 1  11 11  1 1
P. inopinatus PI08 1 1 1 11 11 1  1
L. acidophilus LAP5 1 1 1 1 11 1 1 1
E. faecium TM39     11 1 1 
L. brevis LBR01    1 1   
L. fermentum LF01    1 1 1 1 
L. fermentum LF33 11 1 11 111 111 11 11 11
L. rhamnosus LRH02  1 1 11 11 1 1 11
L. reuteri LRE01  1 1 1 1 1  1
E. casseliflavus ECA01     1   
LAB strains with inhibition zones o 11 mm, 11–16 mm, 17–22 mm and 4 23 mm were classified as strains of no  ; mild 1; strong 11; and very
strong111 inhibition, respectively.
FEMS Immunol Med Microbiol 63 (2011) 44–53 c 2011 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
49Multispecies probiotics against Salmonella invasion
control, F II and F III mice (Fig. 3). For F I mice, Salmonella
counts in the livers and spleens decreased 4–4.5-logs com-
pared with those from the control group. F II and F III mice
showed less inhibitory effects against Salmonella invasion.
The addition of 12% SMP to the multistrain mixture
enhanced the inhibitory effects on Salmonella invasion
significantly. A decrease in Salmonella cells in mouse liver
and spleen of 5–6 logs was observed for F I and F II mice with
SMP-fed mice compared with the control group (Fig. 3).
Discussion
There is evidence that LAB strains play a role in immuno-
modulation and protect the host through anti-infection,
anti-inflammatory and antitumor effects (Jones & Versalo-
vic, 2009). Studies have shown that some LAB strains, such
as Lactobacillus reuteri (Jones & Versalovic, 2009), Lactoba-
cillus rhamnosus GG (Schultz et al., 2003), Lactobacillus
paracasei (Tsai et al., 2008), L. acidophilus (Bleau et al.,
2007), Lactobacillus casei (Ya et al., 2008) and Lactobacillus
plantarum (Pathmakanthan et al., 2004), can enhance
immunity and modulate the immune response in the host.
LAB strains have been shown to stimulate immune cells to
release proinflammatory cytokines such as TNF-a and
interferon-g (Schoenborn & Wilson, 2007). Macrophages
initiate the innate immune response by recognizing patho-
gens, phagocytosing them and secreting inflammatory med-
iators. Recent reports have focused on the possibility that
LAB may activate macrophages and enhance phagocytosis
and may modulate the immune function of an immuno-
compromised host in a strain-dependent manner (Schiffrin
et al., 1997; Blum & Schiffrin, 2003; Lin et al., 2007). In this
study, we selected LAB strains with the ability to induce high
levels of TNF-a in macrophage cells RAW264.7. For phago-
cytic assays, multistrain F I, which consisted of strains with
high TNF-a-inducing activity in macrophages, showed the
highest phagocytic activity among the three multistrain
formulas (Fig. 2). Enhanced phagocytic activity of macro-
phage cells from animals given LAB has been demonstrated
(Paubert-Braquet et al., 1995; Gill et al., 2001). The level of
enhancement appears to depend on the strain, dose and
viability of the LAB used (Gill, 1998). In this study, similar
results were obtained. The phagocytic activity of macro-
phage cells from mice fed with multistrain F I was higher
than that of macrophage cells from mice fed with other
multistrain formulas. Because the LAB strains used in F I
were able to induce high levels of TNF-a production the
most in macrophage cells and enhance the phagocytic
activity of macrophages, these results suggest that the
increased TNF-a production and phagocytotic ability are
two factors that may be involved in the ability of LAB to
inhibit the Salmonella invasion of cultured Caco-2 cells as
well as the survival of this pathogen in the livers and spleens
of mice. Once across the intestinal epithelium in the host,
Salmonella encounter the submucosal macrophages (Ohl &
Miller, 2001). Therefore, the ability of LAB to enhance
TNF-a production as well as the phagocytic activity of macro-
phages may play a critical role in the reduction of populations
of S. Typhimurium in the livers and spleens of mice.
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Fig. 2. Effect of different LAB multistrain formulas on the phagocytic
activity of peritoneal macrophage cells from BALB/c mice. Multistrain
formulas used for F I, F II and F III, respectively; F I, LAB strains LAP5,
TM39, LF33 and LPL05; F II, LAB strains ECA01, PI08, LF01 and PA05; and
F III, LAB strains LF50, LBR01, PA05 and LF01. F II1SMP means that in F II,
12% SMP was added. Significant difference.
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Fig. 3. Salmonella Typhimurium ISM 50 infection at day 8 after
Salmonella challenge in the (a) spleens and (b) livers of the mice. These
mice were fed daily with the multistrain combination or 1 PBS
(negative control) for 63 days before the oral administration of 0.2 mL
of Salmonella cells (5 107 CFU mL1). Mice were fed with multistrain F I,
II and III, with or without SMP, respectively, which consisted of LAB strains
LAP5, TM39, LF33 and LPL05 (F I); ECA01, PI08, LF01 and PA05 (F II); and
LF50, LBR01, PA05 and LF01 (F III). SMP means 12% SMP.
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LAB strains with adhesive abilities may prevent contact
between intestinal epithelial cells and pathogenic bacteria by
mechanisms such as nonspecific steric hindrance of the
receptors for pathogens (Bernet et al., 1994; Coconnier
et al., 2000) or by the competitive exclusion of adherent
pathogenic bacteria (Velraeds et al., 1996). The adherence of
LAB to host intestinal epithelial cells may play an important
role in preventing Salmonella invasion. For example, multi-
strain F II, which contained a Pediococcus strain, i.e. Pedio-
coccus inopinatus PI08, which is able to strongly adhere to
Caco-2 cells, also showed a significant reduction in the level
of Salmonella invasion of Caco-2 cells (Table 2). The
importance of LAB adherence in inhibiting Salmonella
invasion may also play a role in reducing the number of
Salmonella cells found in mice that were fed with multistrain
F I or II plus 12% SMP (Fig. 3). Although the addition of
12% SMP to the multistrain formula did not enhance
phagocytosis of macrophages (Fig. 2), it significantly en-
hanced the inhibitory effects of LAB strains on Salmonella
numbers in the livers and spleens of mice (Fig. 3). This may
be due to an increase in the milk calcium ion concentration,
which enhanced the adherence of LAB strains to intestinal
epithelium (Venegas et al., 2006). In addition, LAB strains
were shown to inhibit the growth of specific pathogenic
bacteria (Table 4). This could be due to the production of
lactic acid and/or bacteriocins (Makras et al., 2006; Simova
et al., 2009). LAB strains used for multistrain preparations
were selected based on their ability to inhibit the growth of
pathogenic bacteria and to adhere to intestinal epithelium
cell line Caco-2 in addition to their immunomodulatory
activity.
According to Nauciel & Espinasse-Maes (1992), the
effects of infection of mice with sublethal doses of S.
Typhimurium can be divided into three main phases. In
the first phase, S. Typhimurium grows exponentially and
invades the spleen and liver. After 7 days, growth inhibited
with this second phase is characterized by a plateau in
Salmonella that lasts about a week. During the third phase,
the number of bacteria progressively declines in both organs.
In this study, the maximum counts of viable Salmonella in
the livers and spleens of mice were determined in the second
(plateau) phase, 8 days after the Salmonella challenge. It was
found that multistrain F I showed the greatest inhibitory
effect on the Salmonella counts in the mouse livers and
spleens (Fig. 3).
For strains in multistrain F I, strains L. acidophilus LAP5,
Lactobacillus fermentum LF33 and Enterococcus faecium
TM39 have been shown to be acid and bile tolerant and
able to adhere to the cultured human intestinal epithelial
cell line Caco-2 (Table 3). These strains have also been
shown able to adhere to the intestinal epithelial cells
isolated from swine, poultry and mice (BALB/c) (Tsai
et al., 2005). In addition, strains LAP5, LF33 and LPL05 in
F I are generally regarded as safe strains (Reid et al., 2006).
Toxicity evaluations for strains of LAP5 as well as TM39 in
vitro and in vivo have also been performed and the results
suggest that these strains are safe to use in humans and
animals (Tsai et al., 2004a, c). Although single strains, such
as LPL05, LAP5 and P. inopinatus PI08, respectively, also
show inhibitory effects on Salmonella invasion of Caco-2
cells just as the F I strains did (Table 2), it should be kept in
mind that in the gastrointestinal tract of the host, multi-
strain probiotics may serve additional functions, such as
creating an anaerobic probiotic niche that enhances the
colonization and adhesion of strains, and enhancing the
additive and synergistic effects due to the combination of
multistrain-specific properties (Ouwehand et al., 2000;
Shihata & Shah, 2000; Timmerman et al., 2004). The
probiotic properties of LAB strains, such as antimicrobial
activity, bile tolerance, growth in milk and survival in host
gastrointestinal tracts, demonstrate the beneficial effects of
multistrain probiotics. The commercially available probio-
tic VSL#3 is an eight-strain formulation; although the
mechanisms of action for the individual strains in VSL#3
are not known, positive clinical outcomes have been
obtained for patients with inflammatory bowel disease
(Bibiloni et al., 2005). Also, a five-strain probiotic combi-
nation including Lactobacillus and Pediococcus spp. has
been shown to reduce pathogen shedding and to decrease
signs of disease in pigs challenged with S. Typhimurium. In
this case, the LAB strains used were selected for their
general probiotic properties, such as antimicrobial activity,
bile and acid tolerance, growth in milk, survival in host
gastrointestinal tracts, etc. (Casey et al., 2007).
In this study, the strains used for the multistrain formula-
tion were those with known specific functions, such as
immunomodulating activity, adherence to intestine epithe-
lium and inhibition of Salmonella invasion of Caco-2 cells.
We showed that their ability to reduce the population of S.
Typhimurium in the livers and spleens of mice was corre-
lated with the results of in vitro assays. In conclusion,
multistrain probiotics, such as F I, which contain strains
with specific functions and mechanisms of action, together
with additional advantages, such as the clonal and the
syngestic effects derived from the combination of these
individual strains, may protect the host; this includes hu-
man and domestic animals. These LAB strains may prove to
be useful as animal feed supplements.
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